Cargando…

Overly broad-spectrum antibiotic treatment of wild-type Pseudomonas aeruginosa infections in relation to the EUCAST new definition of susceptibility testing categories, a retrospective multicentre cohort study

OBJECTIVES: EUCAST changed the definition of the ‘intermediate’ (I) category in 2019, now defined as ‘susceptible, increased exposure’. This new definition could lead to an increased prescription of antibiotics still reported as ‘S’, compared with those now reported as ‘I’. The objective of this stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ourghanlian, Clément, Fihman, Vincent, Morel, Antoine, Lafont, Charlotte, Galy, Adrien, Calimouttoupoulle, Eimma, Woerther, Paul-Louis, Lepeule, Raphaël
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573807/ https://www.ncbi.nlm.nih.gov/pubmed/36267608 http://dx.doi.org/10.1093/jacamr/dlac099

Ejemplares similares

New definitions of susceptibility categories EUCAST 2019: clinic application
por: Díaz, Sandra G. Nabal, et al.
Publicado: (2022)

Blood Cultures for the Diagnosis of Infective Endocarditis: What Is the Benefit of Prolonged Incubation?
por: Fihman, Vincent, et al.
Publicado: (2021)

Intérêt du passage précoce d’un référent infectieux sur l’exposition aux antibiotiques des patients hospitalisés pour COVID-19 – ANTIBIOVID
por: Galy, A., et al.
Publicado: (2021)

Évolution du taux de recours à l’antibiothérapie chez les patients hospitalisés pour COVID-19 – ANTIBIOVID 2
por: Thery, A., et al.
Publicado: (2021)

Antibiotics in Necrotizing Soft Tissue Infections
por: Urbina, Tomas, et al.
Publicado: (2021)

Ampicillin-susceptible Enterococcus faecium infections: clinical features, causal clades, and contribution of MALDI-TOF to early detection
por: Faury, Hélène, et al.
Publicado: (2023)

Instruction videos from EUCAST
Publicado: (2020)

Category Definitions
por: Sittig, Dean F.
Publicado: (2017)

Re: In the name of common sense: EUCAST breakpoints and potential pitfalls. National dissemination of EUCAST guidelines is a shared responsibility
por: Kahlmeter, Gunnar, et al.
Publicado: (2020)

Multicentre Evaluation of the EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) Extending Analysis to 16–20 Hours Reading Time
por: Bianco, Gabriele, et al.
Publicado: (2022)

Impact of selective reporting of antibiotic susceptibility testing results on meropenem prescriptions for the treatment of Pseudomonas aeruginosa infections after 2020 EUCAST criteria update: an observational study in a university hospital
por: Munting, Aline, et al.
Publicado: (2022)

Surface sensing triggers a broad‐spectrum antimicrobial response in Pseudomonas aeruginosa
por: Gdaniec, Bartosz Gerard, et al.
Publicado: (2020)

The Influence of Medium Composition on EUCAST and Etest Antifungal Susceptibility Testing
por: Vahedi-Shahandashti, Roya, et al.
Publicado: (2023)

Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testing of Aspergillus species?
por: Meletiadis, Joseph, et al.
Publicado: (2022)

Vasoplegic Syndrome after Cardiac Surgery for Infective Endocarditis
por: Lim, Pascal, et al.
Publicado: (2022)

Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening
por: DiGiandomenico, Antonio, et al.
Publicado: (2012)

Time to switch from CLSI to EUCAST? A Southeast Asian perspective
por: Cusack, T.P., et al.
Publicado: (2019)

Development of a Broadly Protective, Self-Adjuvanting Subunit Vaccine to Prevent Infections by Pseudomonas aeruginosa
por: Das, Sayan, et al.
Publicado: (2020)

Model-driven characterization of functional diversity of Pseudomonas aeruginosa clinical isolates with broadly representative phenotypes
por: Islam, Mohammad Mazharul, et al.
Publicado: (2023)

Fully Automated EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) from Positive Blood Cultures: Diagnostic Accuracy and Implementation
por: Cherkaoui, Abdessalam, et al.
Publicado: (2022)

Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance
por: Cusack, T.P., et al.
Publicado: (2019)

Updated EUCAST Clinical Breakpoints against Aspergillus, Implications for the Clinical Microbiology Laboratory
por: Guinea, Jesús
Publicado: (2020)

A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical Breakpoints
por: Astvad, Karen Marie Thyssen, et al.
Publicado: (2022)

Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing
por: Matuschek, Erika, et al.
Publicado: (2022)

Ceftaroline Susceptibility among Isolates of MRSA: A Comparison of EUCAST and CLSI Breakpoints
por: Sachu, Arun
Publicado: (2023)

Effect of Two Unique Nanoparticle Formulations on the Efficacy of a Broadly Protective Vaccine Against Pseudomonas Aeruginosa
por: Howlader, Debaki R., et al.
Publicado: (2021)

Antibiotic Susceptibility Profile of Pseudomonas aeruginosa Canine Isolates from a Multicentric Study in Romania
por: Dégi, János, et al.
Publicado: (2021)

Proposal for a New Definition of Categories of Members of the Personnel
Publicado: (1994)

A Multiple Definitions Model of Classification Into Fuzzy Categories
por: Gruenenfelder, Thomas M.
Publicado: (2019)

Case Report: Cerebral Nocardiosis Caused by Nocardia cyriacigeorgica Detected by Metagenomics in an Apparently Immunocompetent Patient
por: Courbin, Virginie, et al.
Publicado: (2022)

Molecular Identification and Antifungal Susceptibility Patterns of Clinical Dermatophytes Following CLSI and EUCAST Guidelines
por: Dabas, Yubhisha, et al.
Publicado: (2017)

EUCAST Susceptibility Testing of Isavuconazole: MIC Data for Contemporary Clinical Mold and Yeast Isolates
por: Jørgensen, Karin Meinike, et al.
Publicado: (2019)

Evaluation of the EUCAST Rapid Antimicrobial Susceptibility Test for Enterobacterales-Containing Blood Cultures in China
por: Shan, Yuzhang, et al.
Publicado: (2022)

EUCAST Ibrexafungerp MICs and Wild-Type Upper Limits for Contemporary Danish Yeast Isolates
por: Jørgensen, Karin M., et al.
Publicado: (2022)

Impact of Definitive Therapy with Beta-Lactam Monotherapy or Combination with an Aminoglycoside or a Quinolone for Pseudomonas aeruginosa Bacteremia
por: Bliziotis, Ioannis A., et al.
Publicado: (2011)

Definitive and Indeterminate Pseudomonas aeruginosa Infection in Adults with Community-acquired Pneumonia: A Prospective Observational Study
por: Sando, Eiichiro, et al.
Publicado: (2021)

Resistance of Pseudomonas Aeruginosa
por: Graevenitz, Alexander Von
Publicado: (1977)

Pseudomonas aeruginosa Biofilms
por: Thi, Minh Tam Tran, et al.
Publicado: (2020)

Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa
por: Hegerle, Nicolas, et al.
Publicado: (2018)

Characterization of a bacteriophage with broad host range against strains of Pseudomonas aeruginosa isolated from domestic animals
por: de Melo, Anna Cristhina Carmine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8lctgl3498v2qm322ghvr5g3vp